Related by context. All words. (Click for frequent words.) 76 elotuzumab 71 INCB# [001] 70 PEG SN# 70 daclizumab 69 HCD# [002] 69 ganetespib 69 docetaxel Taxotere R 69 alvespimycin 69 vicriviroc 69 valopicitabine 69 HuLuc# 69 dacetuzumab 69 atacicept 68 HGS# 68 JAK inhibitor 68 otelixizumab 68 PRT# 68 PXD# 68 posaconazole 68 HGS ETR1 68 BCX# 68 pomalidomide 68 celgosivir 68 HuMax CD# 68 PREZISTA r 68 forodesine 68 cilengitide 67 ocrelizumab 67 CR# vcMMAE 67 R#/MEM # 67 TMC# [001] 67 LY# [003] 67 LymphoStat B 67 Daclizumab 67 Chemophase 67 Golimumab 67 Mipomersen 67 oral prodrug 67 ELND# 67 DermaVir Patch 67 OXi# 67 telaprevir VX 67 Omacetaxine 67 HCV protease inhibitor 67 Nanobody 67 IDX# 67 investigational protease inhibitor 67 axitinib 67 XmAb# 67 relapsed multiple myeloma 67 ISIS # 67 CIMZIA TM 67 pertuzumab 67 BAY #-# 67 Bezielle 67 Nexavar ® 67 PS# [001] 67 talactoferrin 67 Azedra 67 KRN# 67 Phase 2a trial 66 methylnaltrexone 66 PSMA ADC 66 metaglidasen 66 HGS ETR2 66 HuMax EGFr 66 Phase Ib 66 eltrombopag 66 PDE4 inhibitor 66 YONDELIS 66 MYDICAR ® 66 custirsen 66 antisense drug 66 danoprevir 66 Teplizumab 66 MAP# 66 μg dose 66 PSN# [002] 66 class mGluR5 inhibitor 66 Imprime PGG 66 AEG# 66 evaluating tivozanib 66 Traficet EN 66 MGCD# [001] 66 deforolimus 66 Phase 1b 66 investigational monoclonal antibody 66 albinterferon alfa 2b 66 thymalfasin 66 orally administered inhibitor 66 trastuzumab Herceptin R 66 oral ridaforolimus 66 voreloxin 66 Allovectin 7 ® 66 Dapagliflozin 66 MNTX 66 Panzem R NCD 66 CCR5 mAb 66 IAP inhibitors 66 PRX # 66 phase IIb 66 mapatumumab 66 PEG PAL 66 Phase 1b trial 65 Teriflunomide 65 adecatumumab 65 sorafenib tablets 65 Oral NKTR 65 CTAP# Capsules 65 visilizumab 65 Archexin 65 Asentar 65 eniluracil 65 KNS # 65 novel VDA molecule 65 fostamatinib 65 TACI Ig 65 CIMZIA ™ 65 lintuzumab 65 polymerase inhibitor 65 darapladib 65 Elotuzumab 65 integrase inhibitor 65 tanespimycin 65 teriflunomide 65 dexpramipexole 65 phase IIb clinical 65 Zerenex 65 ORENCIA R 65 bendamustine 65 HCV SPRINT 65 EOquin TM phase 65 docetaxel chemotherapy 65 bicifadine 65 lumiliximab 65 oral antiviral 65 XL# XL# XL# 65 subcutaneously administered 65 PF # [001] 65 orally bioavailable 65 Phase Ib clinical 65 SCH # 65 RGB # 65 HuMax CD4 65 Phase 1a 65 RDEA# 65 APOPTONE 65 CoFactor 64 ZYBRESTAT 64 velafermin 64 ALN VSP 64 teduglutide 64 nitazoxanide 64 IMC #B 64 CCX# 64 TMC# [002] 64 neratinib 64 JANUVIA 64 ASONEP 64 ularitide 64 HQK 64 reslizumab 64 Locteron 64 Fibrillex TM 64 sapacitabine 64 IMC A# 64 Aflibercept 64 adecatumumab MT# 64 Amigal 64 SAR# [004] 64 Albuferon 64 OncoVEX GM CSF 64 investigational compound 64 CA4P 64 AP# [003] 64 diabetic neuropathic pain 64 AQ4N 64 virus HCV protease inhibitor 64 talabostat 64 vidofludimus 64 Pimavanserin 64 phase IIa clinical 64 febuxostat 64 decitabine 64 Rebif ® 64 Elvitegravir 64 PLK1 SNALP 64 ascending dose 64 Amrubicin 64 Sym# 64 Tamibarotene 64 HGS ETR1 mapatumumab 64 sunitinib malate 64 BMS # 64 ACZ# 64 MLN# 64 riociguat 64 dose cohorts 64 Bicifadine 64 Blinatumomab 64 subcutaneous formulation 64 GSK# [001] 64 oral antidiabetic 64 PRTX 64 cannabinor 64 CYT# 64 dapagliflozin 64 Genz # 64 perifosine 64 Tarvacin 64 pegylated interferon alfa 2a 64 certolizumab pegol 64 Cethromycin 64 Vitaxin 64 Clolar ® 64 VEGF Trap 64 PD LID 64 AVE# 64 peg interferon 64 TYZEKA 64 Plicera 64 MAGE A3 ASCI 64 docetaxel Taxotere ® 64 antibody MAb 64 non nucleoside inhibitor 64 Elesclomol 64 motesanib 64 Aurora kinase inhibitor 64 perampanel 64 Pegasys ® 64 MYDICAR 64 tenofovir emtricitabine 64 liposomal formulation 64 CD# monoclonal antibody 64 synthetic retinoid 63 regorafenib 63 huC# DM4 63 ACTEMRA TM 63 INTEGRILIN 63 Carfilzomib 63 pradefovir 63 ISENTRESS 63 Factor VIIa 63 6R BH4 63 laquinimod 63 RG# [001] 63 ulimorelin 63 Reverset 63 TG# [003] 63 volociximab 63 Apixaban 63 CBLC# 63 GAMMAGARD 63 Dacogen injection 63 Protexia R 63 rindopepimut 63 MGd 63 Perifosine 63 mcg kg 63 LymphoStat B belimumab 63 Neulasta ® 63 Lenocta 63 nucleoside analog 63 XL# [003] 63 CEQ# 63 tesetaxel 63 JAK2 inhibitor 63 Vandetanib 63 Excellarate 63 Aclidinium 63 nalbuphine ER 63 humanized anti 63 XL# XL# XL# XL# 63 Synavive 63 mGluR5 NAM 63 Pradefovir 63 refractory gout 63 Campath ® 63 romidepsin 63 Telaprevir 63 rFVIIIFc 63 Sapacitabine 63 protease inhibitor 63 Laquinimod 63 iniparib 63 ACTEMRA 63 Epratuzumab 63 proteasome inhibitor 63 GRN#L 63 Ostarine 63 GRNVAC1 63 elagolix 63 placebo controlled Phase 63 tgAAC# 63 treatment naïve genotype 63 adalimumab Humira 63 NGX# 63 LAF# 63 pramlintide 63 tezampanel 63 bavituximab 63 CRx 63 Dasatinib 63 AEGR 63 chronic HCV infection 63 HER2 positive metastatic breast 63 PROMACTA 63 urocortin 2 63 Tanespimycin 63 phase Ib 63 cediranib 63 raxibacumab 63 ixabepilone 63 NP2 Enkephalin 63 Triolex 63 administered subcutaneously 63 investigational humanized monoclonal antibody 63 Phase 2b clinical 63 immunomodulatory 63 DU #b 63 Allovectin 7 R 63 telbivudine 63 limiting toxicity 63 aflibercept 63 tolerated dose MTD 63 angiogenesis inhibitor 63 OMP #M# 63 enzastaurin 63 ISTODAX 63 Muraglitazar 63 Viramidine 63 mipomersen 63 torezolid phosphate 63 systemically administered 63 non nucleoside HCV 63 NV1FGF 63 PHX# 63 Phenoptin 63 Diamyd ® 63 BioNumerik 63 stated Michelle Berrey 63 ongoing Phase 1b 63 Tesetaxel 63 monotherapy 63 Talabostat 63 tolerability 63 teplizumab 62 glufosfamide 62 Fludara 62 Panzem R 62 Tezampanel 62 EOquin TM 62 Cloretazine R VNP#M 62 aflibercept VEGF Trap 62 MDV# 62 TOCOSOL Paclitaxel 62 Copegus ribavirin 62 Lixivaptan 62 vosaroxin 62 relapsed MM 62 Ocrelizumab 62 Phase Ib study 62 vorinostat 62 bardoxolone 62 LY# [002] 62 selective androgen receptor modulator 62 Vidofludimus 62 atrasentan 62 alfa 2a 62 immunomodulator 62 GW# [003] 62 Civacir 62 HCV protease inhibitors 62 multicenter Phase II 62 Tarceva TM 62 lixisenatide 62 RSD# oral 62 MORAb 62 bevirimat 62 obatoclax 62 midstage clinical 62 MGCD# [002] 62 EndoTAG TM -1 62 nucleotide analog 62 L BLP# 62 Allovectin 7 62 Actilon 62 ALN TTR# 62 pharmacodynamic 62 Talactoferrin 62 GALNS 62 Pegasys peginterferon alfa 2a 62 nucleoside reverse transcriptase inhibitor 62 blinded randomized placebo controlled 62 APTIVUS r 62 Atrasentan 62 betrixaban 62 maximally tolerated dose 62 ELACYT 62 regadenoson 62 CANCIDAS 62 Methylnaltrexone 62 dose limiting toxicities 62 mertansine 62 Peg IFN 62 Phase Ib II 62 Randomized Phase 62 azilsartan medoxomil 62 TBC# 62 THALOMID 62 XL# XL# 62 CK # 62 novel topoisomerase 62 rilpivirine 62 TRO# 62 favorable pharmacokinetic profile 62 telaprevir 62 elvucitabine 62 alvimopan 62 IMA# 62 Exelixis XL# 62 boosted protease inhibitor 62 sorafenib Nexavar 62 ridaforolimus 62 Phase IIIb clinical 62 BENLYSTA ® 62 RSD# 62 RG# ITMN 62 ceftaroline 62 TKM ApoB 62 selective modulator 62 BRIM2 62 TDF FTC 62 pan HDAC inhibitor 62 ofatumumab 62 CYCLOSET 62 Phase 1a clinical 62 PI3K/Akt pathway inhibitor 62 Valortim 62 dimebon 62 vandetanib 62 RAPTIVA 62 sitagliptin 62 Nanobody ® 62 phase IIb trial 62 mcg dose 62 Boceprevir 62 low dose cytarabine 62 seropositive patients 62 transcriptase inhibitor NNRTI 62 Omacetaxine mepesuccinate 62 Bortezomib 62 viral kinetics 62 IMiDs ® 62 BARACLUDE R 62 CYT# potent vascular disrupting 62 Anthim 62 Syncria 62 Tyrima 62 Cetrorelix 62 elesclomol 62 ONCONASE 62 MYCAMINE 62 radiation sensitizer 62 imetelstat 62 protease inhibitor PI 62 StemEx 62 Linagliptin 62 UVIDEM 62 temsirolimus 62 belinostat 62 Symadex 62 ALN RSV# 62 Androxal TM 62 pegylated interferon alpha 62 nab paclitaxel 62 Belimumab 62 erlotinib Tarceva ® 62 ALKS 62 TELCYTA 62 Virulizin ® 62 Leukine 62 Phase 2b study 62 tremelimumab 62 humanized monoclonal antibody 62 antiviral activity 62 viral kinetic 62 ospemifene 62 ALN TTR 62 amrubicin 62 investigational compounds 62 GAMMAGARD LIQUID 62 oral deforolimus 62 brivaracetam 62 LymphoStat B TM 62 Phase 1b clinical 62 anti TNF alpha 62 registrational trial 62 FOLOTYN ® 62 Voreloxin 62 HCV protease 62 MAXY alpha 62 MEK inhibitor 62 ritonavir boosted 62 TREANDA 62 Tarvacin TM 61 tolerability profile 61 CCR5 antagonist 61 lintuzumab SGN 61 albiglutide 61 sunitinib 61 REOLYSIN ® 61 Thiovir 61 Sustiva efavirenz 61 PROCHYMAL 61 factor Xa inhibitor 61 Phase IIb trials 61 T DM1 61 AzaSite Plus 61 metastatic hormone refractory 61 bevacizumab Avastin ® 61 Jevtana 61 Zalbin 61 trodusquemine 61 investigational oral 61 FOLOTYN 61 Insegia 61 MKC# MKC# PP 61 rNAPc2 61 Pegasys R 61 tolvaptan 61 INCB# [002] 61 tivozanib 61 GLPG# 61 entinostat 61 castration resistant prostate cancer 61 Aptivus ® 61 Phase 2b trial 61 bortezomib Velcade R 61 compound INCB# 61 phase IIa 61 Phase 2a 61 dose escalation 61 Onconase 61 Pazopanib 61 Protexia ® 61 interferon alfa 61 generation antisense 61 ancrod 61 ARRY 61 AKT inhibitor 61 Neupogen ® 61 rFIXFc 61 Tolerx 61 eculizumab 61 belimumab 61 edoxaban 61 Annamycin 61 SRT# [003] 61 dose cohort 61 Doxil 61 Enzastaurin 61 GRN# 61 APD# 61 cyclophilin inhibitor 61 Azixa 61 milatuzumab 61 ASA# 61 Solazed 61 IRX 2 61 APTIVUS 61 Ixempra 61 Afatinib 61 tipranavir 61 Aliskiren 61 MT# MEDI 61 zanolimumab 61 receptor tyrosine kinase inhibitor 61 tocilizumab 61 telomerase therapeutic 61 apremilast 61 dirucotide MBP# 61 Pertuzumab 61 R sorafenib tablets 61 Ophena TM 61 anakinra 61 PNT# 61 orBec 61 targeted radiotherapeutic 61 uric acid lowering 61 Phase III clinical 61 receptor inhibiting monoclonal 61 LEVADEX 61 bortezomib 61 Aurexis 61 peginterferon alfa 61 Vicriviroc 61 DAVANAT 61 preclinical studies 61 dextromethorphan quinidine 61 EndoTAG 61 oral FTY# 61 unique alkylating agent 61 sodium glucose cotransporter 61 Relivar 61 Pivotal Phase 61 GLYX 61 metreleptin 61 active comparator 61 sorafenib Nexavar R 61 TORISEL 61 NXL# 61 MKC# MT 61 peginesatide 61 Wellstat 61 Gemzar ® 61 mycophenolate mofetil 61 pegylated interferons 61 Phase IIa trial 61 THR beta agonist 61 calcitonin 61 VELCADE melphalan 61 IMP# 61 TMC# C# 61 OncoVEX 61 ANA# 61 preclinically 61 JAK inhibitors 61 polymerase inhibitors 61 ALN PCS 61 CTA# Injection 61 rHuPH# 61 OMP #R# 61 nucleoside analogue 61 Zolinza 61 Nicole Onetto MD 61 FTY# 61 Alocrest 61 epothilone 61 inhaled formulation 61 galiximab 61 lomitapide 61 peg IFN 61 muraglitazar 61 INT# [002] 61 MT#/MEDI-# 61 tezampanel NGX# 61 IMGN# 61 Debio 61 Hsp# Inhibitor 61 baminercept 61 docetaxel Taxotere 61 INSPIRE Trial Phase III 61 Elacytarabine 61 clevidipine 61 GFT# 61 palonosetron 61 Phase IIa clinical 61 PREZISTA rtv 61 Exenatide 61 LUX Lung 61 UPLYSO 61 investigational hepatitis C 61 raltegravir 61 leading oral taxane 61 therapeutic monoclonal antibody 61 OvaRex R 61 anticancer agent 61 JAK1 61 Darusentan 61 Initiate Phase 61 OvaRex ® MAb 61 Ecallantide 61 blinatumomab 61 Pafuramidine 61 samalizumab 61 Indibulin 61 Fx #A 61 bafetinib 61 Relovair 61 TriRima 60 sorafenib Nexavar ® 60 XL# anticancer compounds 60 INTELENCE 60 GGF2 60 lapatinib Tykerb 60 Phase Ib IIa 60 Phase 2b 60 #ME# 60 ENMD # 60 Serdaxin 60 TYGACIL 60 carfilzomib 60 taxane resistant 60 bortezomib Velcade 60 DDP# 60 Seliciclib 60 abiraterone acetate 60 Amplimexon 60 omega interferon 60 lesinurad 60 Hematide ™ 60 Rigel R# 60 Alinia 60 paclitaxel Taxol ® 60 Apoptone 60 exenatide 60 S/GSK# 60 crofelemer 60 Phase IIb 60 Phase 2a clinical 60 mg kg dose 60 IAP inhibitor 60 RhuDex ® 60 Glufosfamide 60 CD# antibody [001] 60 Ceflatonin R 60 R#/MEM 60 Saxagliptin 60 Phase Ib clinical trials 60 pegloticase 60 CCR2 60 diarrhea predominant irritable 60 trastuzumab emtansine T DM1 60 Phase IIa trials 60 cMET 60 ZOLINZA 60 cobicistat 60 PRADAXA 60 HCV RESPOND 2 60 Proellex TM 60 dyskinesia PD LID 60 relapsed myeloma 60 SERMs 60 tasocitinib 60 angioedema indications 60 AERx iDMS 60 Cloretazine 60 generation Hsp# inhibitor 60 ORMD 60 DEB# 60 AVONEX ® 60 antitumor activity 60 TPI ASM8 60 Phase IIb clinical trials 60 refractory CLL 60 anticoagulant reversing agent 60 darunavir 60 Aztreonam lysine 60 daptomycin 60 humanized interleukin 6 60 APEX PD 60 pharmacodynamic effects 60 Vilazodone 60 multi kinase inhibitor 60 CG# [003] 60 PROSTVAC TM 60 SNT MC# 60 Torisel 60 Ceplene/IL-2 60 incyclinide 60 Posiphen 60 glatiramer acetate 60 relapsing multiple sclerosis 60 NEUGENE 60 interferon lambda 60 pharmacokinetic interactions 60 Enhanze Technology 60 Ceflatonin 60 tamibarotene 60 MAXY G# 60 Arimoclomol 60 demonstrated antitumor activity 60 TELINTRA 60 ZADAXIN 60 pralatrexate 60 CIMZIA TM certolizumab pegol 60 Phase IIa 60 Nuvion 60 multicenter Phase 60 SinuNase ™ 60 rilonacept 60 oral salmon calcitonin 60 plus dexamethasone 60 Prochymal 60 Onco TCS 60 Aurora kinase 60 TransVax ™ 60 intranasal delivery 60 #D#C# 60 BYDUREON 60 safinamide 60 ATL# [001] 60 NNRTIs 60 oxymorphone ER 60 mGluR2 positive 60 pegylated liposomal doxorubicin 60 anti leukemic 60 anticancer therapy 60 Pralatrexate 60 Velcade bortezomib 60 HspE7 60 ApoB SNALP 60 lixivaptan 60 investigational pan BCR 60 ZALBIN 60 ALTU 60 NLX P# 60 peginterferon alfa 2b 60 Xanafide 60 Increlex R 60 canakinumab 60 Revimmune 60 vemurafenib 60 tolerability profiles 60 Abiraterone acetate 60 confirmatory Phase III 60 treatment naive genotype 60 DexaSite 60 acyclovir Lauriad R 60 certolizumab 60 Azedra TM 60 Cloretazine ® 60 preclinical 60 PrevOnco 60 IMiDs 60 linaclotide 60 plus Copegus R 60 calcineurin inhibitors 60 alpha 2a 60 Exelixis compounds 60 MBP# [001] 60 VEGF Trap Eye 60 OHR/AVR# 60 targeting CD# 60 velafermin belinostat 60 BENLYSTA TM 60 Taxotere ® 60 Phase #/#a 60 afatinib 60 prodrug 60 ITMN 60 anti TNF 60 ATL/TV# 60 Cimzia ® 60 AeroLEF TM 60 BRAF inhibitor 60 budesonide foam 60 MERLIN TIMI 60 NEUMUNE 60 epothilones 60 Alfimeprase 60 delta isoform 60 MyVax R 60 oral methylnaltrexone 60 idarubicin 60 IFN α 60 Unit Dose Budesonide 60 Phase IIb clinical 60 ZYBRESTAT fosbretabulin 60 agonistic human 60 intranasal formulation 60 PRECiSE 60 interferon gamma 1b 60 nonclinical studies 60 LEXIVA r 60 BYETTA ® 60 Icatibant 60 SARMs 60 inhibitor RG# 60 zalutumumab 60 taribavirin 60 Numax 60 DPP4 inhibitor 60 CIMZIA 60 Excellarate TM 60 CD3 monoclonal antibody 60 multicenter Phase III 60 RLY# 60 Telavancin 60 safety tolerability pharmacokinetics 60 dutogliptin 60 INGN 60 Panitumumab 60 RRMS patients 60 immunotherapeutic agent 60 linagliptin 60 paclitaxel Taxol 60 ENBREL 60 registrational 60 TNF antagonist 60 farletuzumab 60 Meets Primary Endpoint 60 Menerba 60 AZT zidovudine Retrovir 60 receptor inhibitor 60 ambrisentan 60 GED aPC 60 glucokinase activator 60 lubiprostone 60 denufosol 60 EOquin 60 desvenlafaxine succinate 60 AAG geldanamycin analog 60 pharmacodynamic properties 60 epigenetic therapies 60 ciclesonide 60 immunotherapeutic vaccine 60 investigational drug 60 de novo kidney transplant 60 PKC# 60 metformin sulfonylurea 60 darunavir ritonavir 60 Ofatumumab 60 ZD# [001] 60 PEGylated interferon beta 1a 60 REYATAZ R 60 abacavir lamivudine 60 Pegasys plus Copegus 60 MEK inhibitors 60 ALN VSP Phase 60 GVAX ® 60 Epothilones 60 Silodosin 60 AGILECT R 60 Ridaforolimus 60 dasatinib Sprycel ® 60 Clevudine 60 TYKERB 60 radezolid 60 Curaxin 60 DB# [003] 60 Vaxfectin 60 Kahalalide F 60 Hematide 60 AVN# [001] 59 GV# [001] 59 AZD# 59 Omnitarg 59 Oncaspar 59 Achieves Primary Endpoint 59 PEG INTRON 59 vismodegib 59 protease inhibitors 59 Phase 2b Clinical Trial 59 HIV RNA 59 virus HCV infection 59 nucleotide analogue 59 Tipranavir 59 Aptivus 59 CBLB# 59 NOXAFIL 59 cardio renal 59 AVP #D# 59 plus gemcitabine 59 Lung Rx 59 SPRYCEL ® 59 Temsirolimus 59 Phase III Pivotal 59 rhMBL 59 interferon alpha 59 Belinostat 59 Revlimid lenalidomide 59 TAFA# 59 alagebrium 59 Pagoclone 59 ADX# 59 ADP receptor antagonist 59 BiTE antibody 59 telcagepant 59 metastatic castration resistant 59 Cethrin 59 CORT # 59 pharmacokinetic profile 59 tenofovir disoproxil fumarate 59 Neuradiab 59 Aplidin 59 lenalidomide Revlimid R 59 Cariprazine 59 mg kg BID 59 Preclinical studies 59 Dalbavancin 59 ibandronate 59 refractory chronic lymphocytic 59 xanthine oxidase inhibitor 59 CCR5 receptor antagonist 59 CRLX# 59 BEXXAR 59 Noxafil 59 Targretin 59 Bapineuzumab 59 isatoribine 59 oral Janus kinase 59 Myocet 59 TRV# [001] 59 Ozarelix 59 ZK EPO 59 aclidinium bromide 59 Aloxi injection